Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human E inophils

Journal of Experimental Medicine

Volumn 176, Issue 2, 1992, Pages 587-592

  Kameyoshi, Yoshikazu ^a   Dörschner, Albrecht ^b   Mallet, Anthony I ^c   Christophers, Enno ^a   Schröder, Jens M ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b BEIERSDORF AG   (Germany)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; AMINO ACID; CHEMOATTRACTANT; CHEMOTAXIN; CYTOKINE; EOSINOPHIL CHEMOTACTIC FACTOR; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; THROMBIN;

AMINO ACID SEQUENCE; ARTICLE; ASTHMA; DOSE RESPONSE; EOSINOPHIL; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LEUKOCYTE MIGRATION; MASS SPECTROMETRY; MEMORY CELL; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SKIN MANIFESTATION; T LYMPHOCYTE; THROMBOCYTE;

AMINO ACID SEQUENCE; BLOOD PLATELETS; CHEMOTACTIC FACTORS, EOSINOPHIL; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; EOSINOPHILS; HUMAN; LYMPHOKINES; MOLECULAR SEQUENCE DATA; PLATELET ACTIVATION; RANTES; SUPPORT, NON-U.S. GOV'T; THROMBIN;

EID: 0026766903     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.176.2.587     Document Type: Article

References (30)

1. Baggiolini, M., A. Walz, and S.L. Kunkel. 1989. Neutrophil-activating peptide-l/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest. 84:1045.
2. Gronhoj-Larsen, C., A.O. Anderson, E. Appella, J.J. Oppenheim, and K. Matsushima. 1989. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science (Wash. DC). 243:1464.
3. Schröder, J.-M., U. Mrowietz, E. Morita, and E. Christophers. 1987. Purification and partial biochemical characterization of a human monocyte-derived neutrophil-activating peptide that lacks Interleukin 1 activity. J. Immunol. 139:3474.
4. Yoshimura, T., K. Matsushima, S. Tanaka, E.A. Robinson, E. Appella, J.J. Oppenhaim, and E.J. Leonard. 1987. Purification of a human monocyte-derived neutrophil chemotactic factor that shares sequence homology with other host defense cytokines. Proa Natl. Acad. Sei. USA. 84:9233.
5. Van Damme, J., J. Van Beeumen, G. Opdenakker, and A. Bil-liau. 1988. A novel, NH2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive and granulocytosis-promoting activity. J. Exp. Med. 167:1364.
6. Schröder, J.-M., N. Persoon, and E. Christophers. 1990. Lipopolysaccharide-stimulated human monocytes secrete apart from neutrophil-activating peptide 1/interleukin 8 a second neutrophil-activating protein: NHî-terminal amino acid sequence identity with melanoma growth stimulatory activity. J. Exp Med. 171:1091.
7. Moser, B., I. Clark-Lewis, R. Zwahlen, and M. Baggiolini. 1990. Neutrophil-activating properties of the melanoma growth-stimulatory activity. J. Exp Med. 171:1797.
8. Walz, A., B. Dewald, V. von Tschamer, and M. Baggiolini. 1989. Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III, and platelet factor 4 on human neutrophils. J. Exp Med. 170:1745.
9. Matsushima, K., C. G. Larsen, G. DuBois, and J.J. Oppenheim. 1989. Purification and characterization of a novel monocyte chemotactic and activating factor produced by human my-elomonocytic cell line. J. Exp Med. 169:1485.
10. Yoshimura, T., N. Yuhki, S.K. Moore, E. Appella, M.I. Lerman, and E.J. Leonard. 1989. Human monocyte chemoat-tractant protein-1 (MCP-1): full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS (Fed. Eur. Biochem. Soa) Lett. 244:487.
11. Schall, T.J., K. Bacon, K.J. Toy, and D.V. Goeddel. 1990. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RIANTES. Nature (Lond.). 347:669.
12. Schall, T.J. 1991. Biology of the RANTES/SIS cytokine family. Cytokine. 3:165.
13. Morita, E., J.-M. Schröder, and E. Christophers. 1990. Identification of a novel and highly potent eosinophil chemotactic lipid in human eosinophils treated with arachidonic acid. J. Immunol. 144:1893.
14. Schroder, J.-M., M. Sticherling, N.-L.M. Persoon, and E. Christophers. 1990. Identification of a novel platelet-derived neutrophil-chemotactic polypeptide with structural homology to platelet factor 4. Biochem. Biophys. Res. Commun. 172:898.
15. Walz, A., and M. Baggiolini. 1989. A novel cleavage product of /3-thromboglobulin formed in cultures of stimulated mononuclear cells activate human neutrophils. Biochem. Biophys. Res. Commun. 159:969.
16. Yoshimura, T., E.A. Robinson, S. Tanaka, E. Appella, and E.J. Leonard. 1989. Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human blood mononuclear leukocytes. J. Immunol. 142:1956.
17. Castor, C.W., J.W. Miller, and D.A. Walz. 1983. Structural and biological characteristics of connective tissue activating peptide (CTAP-III), a major human platelet-derived growth factor. Proa Natl. Acad. Sci. USA. 80:765.
18. Walz, A., and M. Baggiolini. 1990. Generation of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteases. Biochem. Biophys. Res. Commun. 171:449.
19. Deuel, T.F., P.S. Keim, M. Fanner, and R.L. Heinrikson. 1977. Amino acid sequence of human platelet factor 4. Proa Natl. Acad. Sci. USA. 74:2256.
20. Wardlaw, A.J., R. Moqbel, O. Cromwell, and A.B. Kay. 1986. Platelet activating factor. A potent chemotactic and chemoki-netic factor for eosinophils. J. Clin. Invest. 78:1701.
21. Schall, T.J., J. Jongstra, RJ. Dyer, J. Jorgensen, C. Claylberger, M.M. Davis, and A.M. Krensky. 1988. A human T cell-specific molecule is a member of a new gene family. J. Immunol. 141:1018.
22. Clore, G.M., and A.M. Gronenbom. 1992. NMR and X-Ray Analysis of the three-dimensional structure of interleukin-8. In Interleukin-8 (NAP-1) and Related Chemotactic Cytokines. Cytokines, Vol. 4. M. Baggiolini, and C. Sorg, editors. Karger, Basel. 18-40.
23. Gleich, G.J. 1990. The eosinophil and bronchial asthma: current understanding. J. Allergy Clin. Immunol. 85:422.
24. Frew, A.J., and A.B. Kay. 1990. Eosinophils and T-Lymphocytes in late phase allergic reactions. J. Allergy Clin. Immunol. 85:533.
25. Wang, J.M., A. Rambaldi, A. Biondi, Z.G. Chen, C.J. Sanderson, and A. Mantovani. 1989. Recombinant human interleukin 5 is a selective eosinophil chemoattractant. Eur. J. Immunol. 19:701.
26. Rand, T.H., WW. Cruikshank, D.M. Center, and P.F. Weller. 1991. CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration. J. Exp Med. 173:1521.
27. + cellular infiltrate associated with allergen-induced late-phase skin reactions in atopic subjects. Clin. Exp Immunol. 84:270.
28. Page, C.P. 1989. Platelets as inflammatory cells. Immunophar-macology. 17:51.
29. Lellouch-Tubiana, A., J. Lefort, M.-T. Simon, A. Pfister, and B.B. Vargaftig. 1988. Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists. Am. Rev. Respir. Dis. 137:948.
30. Coyle, A.J., C.P. Page, L. Atkinson, R. Flanagan, and W.J. Metzger. 1990. The requirement for platelets in allergen-induced late asthmatic airway obstruction. Eosinophil infiltration and heightened airway responsiveness in allergic rabbits. Am. Rev. Respir. Dis. 142:587.